CERDELGA

Identification of Cerdelga

No description

Google image searchProduct monograph

Active ingredient

eliglustat (eliglustat tartrate), 84 MG

DIN: 02463261

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: SANOFI-AVENTIS CANADA INC

Date: 17-APR-2024

ATC:

• A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
• A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
• A16AX — Various alimentary tract and metabolism products (ATC, ATC/DDD)
• A16AX10 — ELIGLUSTAT (ATC/DDD)

Reference brand drug: Cerdelga

External Links for Cerdelga

Search on Google

• Cerdelga side effects
• Cerdelga dosage
• eliglustat side effects
• eliglustat dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find cerdelga photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.